Item 7.01 Regulation FD Disclosure.

During the week of January 12, 2020, representatives of Seneca Biopharma, Inc. ("Company") presented at both the Sachs Associates 3rd Annual Neuroscience Innovation Forum and the Biotech Showcase, both of which were held in San Francisco, California. The representatives are also conducting one-on-one meetings with potential joint venture and strategic partners. Filed herewith as Exhibit 99.01 are the slides that were presented at such conferences. The slides are also available on the Company's website at www.senecabio.com.

The information contained in this Current Report on Form 8-K and the exhibits attached hereto shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall such information or such exhibits be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. The information set forth in or exhibits to this Form 8-K shall not be deemed an admission as to the materiality of any information in this report that is required to be disclosed solely to satisfy the requirements of Regulation FD.

© Edgar Online, source Glimpses